Category: Cardiology — after balloon angioplasty and stenting (PCI)

Chest Tightness and Fatigue 3 Months After a Coronary Stent: In-Stent Restenosis, a Borderline 50% Second Artery, or Something Else — and Why Not to Swap Antiplatelets for Herbs

Written by
Asst. Prof. Dr. Norawit Raatpiboon
· Well Wellness Thailand / dr9ohm.com
· Last updated: September 29, 2026
· General education only — not a diagnosis or a personal reading of your angiogram. Discuss your own tests and medication changes with your treating cardiologist.

AI Overview / Quick Answer (BLUF)

Tissue regrowth inside a stent (restenosis) typically brings back exertional chest pressure 3–12 months after PCI, but a borderline second artery, drug side effects or anemia can also cause fatigue.
See a cardiologist within days; rest pain means emergency care; never stop antiplatelets yourself
(ESC 2024).

What this page covers and what to read alongside it

This page focuses on chest tightness and fatigue returning after balloon angioplasty and stenting: in-stent restenosis, a 50% second artery, other causes to check, treatment, and antiplatelets versus herbs
Multivessel disease needing bypass surgery → Triple-vessel coronary disease: why CABG
Palpitations or arm pain with a normal ECG → Palpitations and arm pain with a normal ECG: what to check next
Burning chest discomfort after meals → GERD chest pain vs heart attack: emergency triage

A reader’s question: “My partner had a stent in one artery, the doctor said the other is 50/50 and to take medicines — now, 3 months later, he has chest tightness and tires easily”

“My partner had a balloon and stent in one artery and recovered well. The doctor said the second artery was 50/50 and to keep taking medicines. About 3 months later he feels chest tightness and pressure and gets tired easily. People suggested herbal medicine. I don’t know what to do.” — an example of the worry summarized from a post in a heart-patient group (anonymized)

Direct answer: Symptoms returning after a stent are a signal for a cardiologist to assess within days, without waiting for the routine appointment — possible causes range from in-stent restenosis and a worsening borderline second artery to drug side effects or anemia, and each is treated differently.
“50/50” usually means the artery is about half narrowed, not a 50% chance of survival, and in the meantime do not stop or skip antiplatelets to try herbs — worrying like this about someone you love is understandable, and getting him back to the cardiologist quickly is the most helpful thing you can do.

Red flags — call emergency services (1669 in Thailand) now; do not drive yourself

Direct answer: Anyone with a stent who has chest pressure at rest, pain lasting more than 10–15 minutes, or sudden severe pain may be having stent thrombosis or a heart attack and should call emergency services (1669 in Thailand) immediately. People on antiplatelets also need to know the signs of serious bleeding.

Call emergency services / go to the ER now

Chest pressure, squeezing or heaviness at rest, or waking up with chest pain
Pain lasting more than 10–15 minutes that does not ease with rest
If you have been prescribed sublingual nitroglycerin, use it as your doctor instructed — if pain is not better or is worse 5 minutes after one dose, call emergency services at once rather than waiting through several doses
Pain with sweating, nausea or breathlessness, or spreading to the arm, jaw, neck or back
Fainting or near-fainting, or a racing heartbeat that will not stop
Sudden severe breathlessness or being unable to lie flat
Exertional pain that within days becomes much more frequent, longer, or brought on by minimal effort

Serious bleeding on antiplatelets — go to the ER

Black, tarry stools or passing a large amount of blood
Vomiting blood or brown coffee-ground material
Sudden severe headache, weakness on one side, slurred speech or drowsiness — possible bleeding in the brain

While waiting for the ambulance

Sit and rest, loosen tight clothing, do not walk or drive yourself, and have your full medicine list and stent date ready
If you already take aspirin daily, do not take extra on your own unless the emergency dispatcher or a doctor advises it
If the person collapses and is not breathing, start chest compressions (CPR) and find an AED as the dispatcher directs

Not an emergency, but see your cardiologist within days — do not wait for the routine appointment

Chest tightness or breathlessness with less exertion than before, such as needing to stop on a usual walk — even if it settles with rest
New tiredness or breathlessness since starting a medicine such as ticagrelor or a beta-blocker — tell your doctor, but do not stop it yourself
Missed or stopped antiplatelet doses for several days — tell your doctor at once to restart safely
Pallor, weakness, palpitations or light-headedness on standing, or unusual gum bleeding and easy bruising

When you call, say when the coronary stent was placed, which antiplatelets you take, and how many minutes the pain has lasted — and bring your ECGs and procedure report if you have them.

Decision pathway: what to do when symptoms return after a stent

Direct answer: The first question is whether there is a red flag right now. If yes, call emergency services. If not, see a cardiologist within days to review medicines, check for anemia, compare the ECG with previous ones, and then test for ischemia or look at the stent and second artery by angiography as appropriate.

Chest tightness or fatigue returning after a stentIs any red flag present?

Yes, a red flagPain at rest or over 10–15 minutes, no relief 5 minutes after nitroglycerin, sweating, fainting, or serious bleeding

Emergency services / ERECG compared with old tracings, troponin, and possibly emergency coronary angiography

No, but symptoms are back or worseSee a cardiologist within days rather than at the routine visit

Check easily fixable causes firstMedicine review and adherence · blood count for anemia · ECG comparison · echocardiogram

Test for ischemiaStress imaging, or angiography with FFR/iFR and IVUS/OCT inside the stent

Treat the causeRestenosis · significant second artery · drug side effect · anemia · vasospasm · heart failure

Summarized from ESC 2024, AHA/ACC 2023 and Crea 2019 — not a diagnostic tool; the actual order of tests depends on your doctor.

Timeline after a stent: when each problem tends to occur

0–30 days: early stent thrombosisRare but dangerous; sudden severe heart-attack pain; highest risk if antiplatelets are stopped — still possible, though less common, after 30 days

1–12 months (usually about 3–12): in-stent restenosisTissue gradually thickens inside the stent; exertional chest pressure slowly returns

Any time: disease progression elsewherePlaque in the second artery or a new spot grows — prevented with lipid-lowering drugs, blood pressure and glucose control, and not smoking

1. What a “50/50” second artery means and how doctors decide whether to stent it

Direct answer: “50/50” usually means an intermediate (borderline) stenosis of about 50% of the artery width — not a 50% chance. The angiogram percentage alone cannot show whether the narrowing truly limits flow, so doctors measure it with FFR ≤0.80 or iFR ≤0.89, or use stress imaging
(Vrints C, ESC 2024).

FFR and iFR: measuring whether a narrowing truly causes ischemia

During coronary angiography, a pressure wire is passed across the narrowing to compare the pressure beyond it with aortic pressure. FFR (fractional flow reserve) is measured during a vessel-dilating drug; a value of 0.80 or lower indicates a significant narrowing. iFR is measured at rest without the drug, using a threshold of 0.89 or lower. In DEFINE-FLAIR (2,492 patients), iFR-guided decisions were non-inferior to FFR (1-year events 6.8% vs 7.0%)
(Davies JE, NEJM 2017).

Angiography alone

18.3% events at 1 year

FFR ≤0.80 guidance

13.2%

In FAME (1,005 patients with multivessel disease), stenting only lesions with FFR ≤0.80 reduced death, heart attack and repeat procedures at 1 year from 18.3% to 13.2%, using fewer stents
(Tonino PA, NEJM 2009).

If the measurement is not significant, are medicines safe?

DEFER followed intermediate lesions with FFR ≥0.75 for 5 years: cardiac death or heart attack occurred in 3.3% of the deferred group versus 7.9% of those stented — the risk from that lesion was under 1% per year and was not reduced by stenting
(Pijls NH, JACC 2007).
This is why a doctor may say “take medicines for now” — but if symptoms change, the assessment must be repeated.

Borderline narrowings can grow over time

PROSPECT followed 697 patients after PCI: 3-year cardiac events were 20.4%, arising from treated sites in 12.9% and untreated sites in 11.6%; many of those untreated sites were only mildly narrowed at first (mean 32.3%) but had a large plaque burden or thin-capped plaque
(Stone GW, NEJM 2011)
— so controlling cholesterol, blood pressure and glucose and stopping smoking matter as much as the stent itself.

2. In-stent restenosis versus stent thrombosis

Direct answer: In-stent restenosis is tissue gradually thickening inside a stent; with current drug-eluting stents it leads to repeat procedures at about 1–2% per year, usually within 3–12 months. Stent thrombosis is sudden, rare, and far more dangerous
(Giustino G, JACC 2022).

How restenosis develops

Balloon angioplasty and stenting (PCI) injures the artery wall, and the body repairs it by growing new tissue over the stent. In some people this tissue grows too thick and narrows the artery again (neointimal hyperplasia); later, new plaque can form inside the stent (neoatherosclerosis). Risk rises with an underexpanded stent, long stents or small arteries, diabetes, and chronic kidney disease.

How common it is and how it presents

A 2022 JACC review notes that despite much better drug-eluting stents, restenosis requiring repeat revascularization still occurs at about 1–2% per year
(Giustino 2022).
In a US registry of over 5.1 million PCI patients, about 10.6% of PCIs were for restenosis, and about 25% of these patients presented with an acute heart attack
(Moussa ID, JACC 2020).

Symptoms that suggest restenosis

Most often it is angina that gradually returns with exertion, similar to symptoms before the procedure, typically 3–12 months after stenting and easing with rest — but some people present with acute pain, so do not wait.

How restenosis is treated

Guidelines recommend repeat angiography with intravascular ultrasound or optical imaging (IVUS or OCT) to find underexpansion or tissue growth, then treatment with a drug-coated balloon or a repeat drug-eluting stent; people with repeated restenosis or complex multivessel disease may be considered for bypass surgery
(ESC/EACTS 2018;
Giustino 2022).

Stent thrombosis: rare but dangerous

In 2,229 real-world patients with first-generation drug-eluting stents, stent thrombosis occurred in 1.3% at 9 months, 45% of those affected died, and the strongest predictor was premature antiplatelet discontinuation (hazard ratio about 90), followed by kidney failure, bifurcation lesions, diabetes and low ejection fraction
(Iakovou I, JAMA 2005).
Newer stents have lower rates, generally under 1% per year
(ESC DAPT 2017)
— it causes sudden severe heart attack pain and needs emergency services.

3. Other causes of chest tightness and fatigue after a stent that must be checked

Direct answer: Angina persists or returns after PCI in about 20–40% of patients during short to medium-term follow-up, and it does not always come from the stent — doctors need to check for ischemia and for fixable causes such as drug side effects, anemia or a weaker heart pump, always ruling out heart causes first
(Crea F, Eur Heart J 2019).

Table of causes of recurrent symptoms after PCI: mechanism, typical timing, clues and tests

Cause	Mechanism	Typical timing	Clues	Test
In-stent restenosis	Tissue thickening inside the stent, or new plaque inside the stent	About 3–12 months after stenting	Exertional chest pressure gradually returning, similar to pre-procedure symptoms	Stress imaging, or angiography with IVUS/OCT
Second artery or another spot narrowing further	Plaque growing enough to limit flow, or a known untreated lesion	Any time	Exertional pain in someone told another artery is borderline	FFR ≤0.80 or iFR ≤0.89, or stress imaging
Stent thrombosis	Platelets clumping on stent struts not yet covered by lining cells	Highest in the first 30 days, rare afterwards	Sudden severe pain and sweating, often after stopping or missing antiplatelets	Emergency: ECG, troponin and immediate angiography
Ticagrelor-related breathlessness	A drug effect on the adenosine system, not ischemia	Usually starts in the first days to weeks after starting	Air hunger at rest, not clearly linked to exertion, without chest pain	Doctor rules out heart and lung causes, then considers switching within the class
Anemia from bleeding	Dual antiplatelets increase gastrointestinal bleeding; less blood carries less oxygen	While on dual antiplatelet therapy	Pallor, weakness, palpitations, black stools, light-headedness on standing	Blood count, iron studies, and endoscopy when indicated
Beta-blocker effects	Slower heart rate and gentler contraction	After starting or increasing the dose	Fatigue, tiring quickly on exertion, very slow resting pulse, light-headedness	Pulse count and ECG, then dose adjustment by the doctor — do not stop it yourself
Coronary spasm or small-vessel dysfunction	Large or small coronary vessels constrict even though the stent is open	Any time	Pain at rest, at night or early morning, or pain despite a good angiogram	Angiography with spasm testing and microvascular flow measurement at specialist centers
Heart failure or reduced pumping	Heart muscle previously starved of blood pumps less strongly	After a heart attack or as disease progresses	Breathless lying flat, ankle swelling, rapid weight gain	Echocardiogram and NT-proBNP blood test
Reflux or esophageal causes	Antiplatelets irritate the gut lining; reflux causes central chest discomfort	After meals or lying down	Burning central chest, sour burps, not linked to exertion	Rule out heart causes first, then assess the digestive tract
Anxiety or deconditioning after a long rest	An alert autonomic nervous system and muscle weakness from inactivity	Weeks to months after the procedure	Palpitations, fear the stent will block, easy fatigue with no ischemia on testing	Diagnosed only after physical causes are excluded; cardiac rehabilitation helps

Summarized from Crea 2019, Giustino 2022, PLATO 2009 and EAPCI 2020 — clues aid thinking; they do not replace testing.

Ticagrelor breathlessness: common, but do not stop it yourself

In PLATO, breathlessness occurred in 13.8% of patients on ticagrelor versus 7.8% on clopidogrel, mostly mild
(Wallentin L, NEJM 2009).
If you suspect it, tell your cardiologist — they will rule out heart, lung and anemia causes first and may switch to another P2Y12 antiplatelet without any gap in treatment.

Anemia from gastrointestinal bleeding

Anemia makes the heart work harder and brings on chest tightness even when the stent is open. Watch for black stools and pallor, and check a complete blood count for gastrointestinal bleeding (NIDDK). Doctors often add a PPI such as omeprazole to dual antiplatelets in people at risk; in COGENT, omeprazole cut gastrointestinal events at 180 days from 2.9% to 1.1% without increasing cardiac events (4.9% vs 5.7%)
(Bhatt DL, NEJM 2010).

Other causes your doctor will consider

Beta-blockers — can cause fatigue or a slow heart rate; the dose can be adjusted, but do not stop suddenly, as this can cause rebound chest pain or a fast heart rate
Coronary artery spasm and small-vessel disease — pain despite an open stent; per the EAPCI 2020 consensus, testable at specialist centers (Kunadian V, Eur Heart J 2020)
Heart failure — breathless lying flat, ankle swelling; checked with an echocardiogram
Reflux — burning after meals, but heart causes come first; read GERD chest pain vs heart attack
Anxiety and deconditioning — common after serious illness; improves with cardiac rehabilitation

Questions to bring to your cardiologist

Analyze severity and receive personalized guidance from our Advisory team — take the Heart Symptom Signal Check to see whether your pattern deserves testing and how urgent it is, then bring the questions below to your cardiologist.

Do these returning symptoms fit in-stent restenosis or a worsening second artery, and do I need stress testing or repeat angiography?
How narrowed is the second artery, and has FFR or iFR been measured? What was the value?
How long do I need dual antiplatelets, and what happens if I need dental work or surgery?
Could my tiredness come from a medicine such as ticagrelor or a beta-blocker?
Should I have a blood count, and do I need an acid-reducing medicine to protect my stomach?
What is my LDL now — is it below 55 mg/dL — and where can I join cardiac rehabilitation?

Chest pressure at rest or over 10–15 minutes, no relief 5 minutes after nitroglycerin, sweating or fainting: call emergency services (1669 in Thailand) first — this check and checklist are not a diagnosis (see red flags that must not wait).
Take the Heart Symptom Signal Check (free)

4. Which tests are needed when symptoms return, and how urgently

Direct answer: Exertional pain that is new or worsening after a stent means seeing a cardiologist within days; pain at rest means the ER. Testing starts with an ECG compared with previous tracings, a blood count and an echocardiogram, followed by stress imaging or angiography with FFR/iFR and IVUS/OCT
(Virani SS, AHA/ACC 2023).

First-line tests

Electrocardiogram (ECG) — most useful when compared with the post-procedure tracing, so keep copies
Troponin — when pain occurs at rest or lasts long, to rule out heart muscle damage
Blood count, kidney function, electrolytes, glucose and lipids — to find anemia and check whether LDL is at target
Echocardiogram — pumping function and valves

Testing for ischemia and imaging the arteries

Stress imaging — stress echocardiography, nuclear scanning (SPECT) or stress cardiac MRI shows where ischemia is, and performs better than an exercise ECG alone
Coronary angiography — when symptoms are typical or worsening quickly, with FFR or iFR of the second artery and IVUS or OCT inside the stent, so treatment can be chosen in one session
Coronary CT angiography — limited view inside stents, especially small or heavily calcified ones, so it is usually not the first test after stenting

Urgency: pain at rest or over 10–15 minutes → emergency services (1669) · new, more frequent, or lower-threshold exertional pain → cardiologist within days · mild stable tiredness without chest pain → tell your doctor before or at the next visit
(ESC 2023 ACS)

5. Treatment: medicines, repeat procedures, surgery and cardiac rehabilitation

Direct answer: Treatment depends on the cause — restenosis is treated with a drug-coated balloon or repeat drug-eluting stent; the second artery is stented when FFR ≤0.80 or iFR ≤0.89; complex multivessel disease may need bypass surgery (CABG); and everyone needs antiplatelets, lipid-lowering to an LDL below 55 mg/dL and cardiac rehabilitation
(ESC 2024;
ESC/EAS 2019).

Comparison table: optimizing medicines vs repeat procedures vs bypass surgery vs rehabilitation vs herbs

Option	Benefits	Limits / risks	Who it fits
Optimizing anti-anginal medicines	Quick symptom relief: beta-blockers, calcium channel blockers, long-acting nitrates (isosorbide mononitrate), ranolazine or trimetazidine where available	Does not fix the narrowing; side effects such as headache, low blood pressure, slow pulse; nitrates must not be combined with PDE5 inhibitors	Everyone while awaiting tests, and people with mild ischemia or non-significant lesions
Repeat angiography and treating restenosis with a drug-coated balloon or drug-eluting stent	Reopens the restenosed segment and fixes mechanical causes such as underexpansion when guided by IVUS/OCT	Procedural risks; restenosis can recur; antiplatelets must continue	Clear symptoms or clear ischemia with restenosis found inside the stent
Stenting the second artery when FFR/iFR is significant	In FAME, FFR guidance cut 1-year events from 18.3% to 13.2%	If FFR is above 0.80 or iFR above 0.89, stenting does not reduce risk (DEFER)	Symptomatic borderline lesions with FFR ≤0.80 or iFR ≤0.89
Bypass surgery (CABG)	Builds detours around several narrowings; good long-term results in complex multivessel disease or diabetes	Major surgery with longer recovery; needs Heart Team assessment	Complex multivessel disease, repeated restenosis, or anatomy difficult for PCI
Risk-factor control, lipid-lowering and cardiac rehabilitation	High-intensity statin (atorvastatin, rosuvastatin) ± ezetimibe ± PCSK9 inhibitor to LDL below 55 mg/dL; rehabilitation reduces heart attacks (RR 0.72) and hospital admissions (RR 0.58)	Needs long-term commitment; statin muscle aches occur in some people and can be managed by the doctor	Everyone after a stent, whatever other treatment is chosen
Herbs, supplements and Thai traditional medicine	No evidence they reopen arteries or replace stents and medicines; may offer comfort as complementary care	Many increase bleeding or alter drug levels; the most dangerous step is stopping antiplatelets to switch to herbs	Complementary use only, with the cardiologist and pharmacist aware of every product

Summarized from ESC 2024, ESC/EACTS 2018, FAME, DEFER and Cochrane 2021 — drug names are generic names or classes; choice and dose are your doctor’s decision.

How long dual antiplatelet therapy (DAPT) lasts

Dual antiplatelet therapy means aspirin plus a P2Y12 inhibitor (clopidogrel, prasugrel or ticagrelor), generally for about 6 months after PCI for chronic coronary disease and about 12 months after an acute coronary syndrome (ACS). It may be shorter (for example 1–3 months) in people at high bleeding risk, at the doctor’s discretion, followed by a single antiplatelet long term
(ESC 2023 ACS;
ESC 2024 CCS;
AHA/ACC 2023;
ESC DAPT 2017).
Never stop or skip doses yourself, and tell every doctor and dentist before any procedure.

LDL cholesterol target

The 2019 ESC/EAS guideline recommends that people with coronary disease lower LDL by at least 50% and to below 55 mg/dL (1.4 mmol/L) with a high-intensity statin, adding ezetimibe and then a PCSK9 inhibitor if the target is not reached
(Mach F, ESC/EAS 2019).

Cardiac rehabilitation

A 2021 Cochrane review of 85 trials (23,430 people) found that exercise-based cardiac rehabilitation reduced heart attacks at 6–12 months (RR 0.72) and all-cause hospital admissions (RR 0.58)
(Dibben G, Cochrane 2021).
Rehabilitation also helps people learn their safe exertion limits, reduces fear, and lets the team fine-tune medicines.

6. Antiplatelets vs herbs: why not to stop medicines for herbal remedies

Direct answer: No herbal remedy has been shown to reopen a narrowed artery or replace stents and antiplatelets. Premature antiplatelet discontinuation is the strongest risk factor for stent thrombosis, and many herbs increase bleeding or change drug levels when combined — one review documented 306 interactions between anticoagulant or antiplatelet drugs and 90 Chinese herbal medicines
(Tsai HH, PLoS One 2013).

Table of antiplatelets vs herbs and supplements: evidence, bleeding or interaction risk, and what to do

Drug / product	Evidence after stenting	Bleeding / interaction risk	What to do
Dual antiplatelets (aspirin + clopidogrel, prasugrel or ticagrelor)	The strongest evidence; prevents stent thrombosis and repeat heart attacks	Easier bleeding, especially in the gut; reduced with a PPI in people at risk	Take on time every day as prescribed; never stop or skip doses yourself
Ginkgo	No evidence it prevents restenosis or heart attacks	Reported to raise bleeding risk with antiplatelets	Avoid unless your cardiologist agrees
Garlic extract tablets or capsules	No evidence it replaces medicines or reopens arteries	Concentrated extracts may increase bleeding (garlic in normal food is not a problem)	Tell your doctor and pharmacist before use, and stop before procedures as instructed
High-dose turmeric / curcumin	No evidence for major heart outcomes	Listed in reviews as raising bleeding risk with antiplatelets	Turmeric in food is fine; ask your doctor before high-dose capsules
Dong quai, danshen, high-dose ginger, licorice	No evidence they can replace antiplatelets	Among the herbs a review found to increase bleeding through additive antiplatelet or anticoagulant effects	Avoid while on dual antiplatelets unless your doctor agrees
Ginseng	No evidence it prevents re-narrowing	May affect clotting and blood glucose; interaction data are unclear	Tell your doctor, especially if you also have diabetes
High-dose fish oil	Does not replace antiplatelets or lipid-lowering drugs	High doses may slightly increase bleeding tendency with anticoagulants or antiplatelets	Use only the dose and type your doctor recommends
St John’s wort	No role in treating coronary disease	Induces the liver enzyme CYP3A4; a study found it increased clopidogrel’s antiplatelet effect, and it may lower ticagrelor and some statin levels	Avoid, and tell your doctor if you already use it
Mixed herbal or Thai traditional remedies with unknown ingredients	No studies showing they reopen arteries or replace treatment	Unpredictable; some products may be contaminated or contain undeclared prescription drugs	Show every bottle or label to your doctor or pharmacist; complementary use only

Summarized from Tsai 2013, Lau 2011, Iakovou 2005 and NCCIH herb fact sheets — overview at Herbal Medicine (MedlinePlus)

If the family wants to use Thai traditional medicine too

Use it as complementary care, such as gentle massage that avoids pressing on the chest, or relaxation — never as a replacement for medicines or testing
Show every product — herbal medicines, teas, supplements — to the cardiologist or pharmacist before using it
Tell every doctor and dentist that you take antiplatelets before extractions, endoscopy or surgery; do not stop them because a dentist or friend suggests it

7. What the patient and family can do now

Direct answer: While waiting to see the cardiologist, what helps most is taking every medicine on time, keeping a symptom diary of how much exertion brings symptoms on and how long they last, and preparing documents — the procedure report, ECGs and a full medicine list — while knowing the signs that mean calling 1669.

Keep a symptom diary for the doctor

What brings symptoms on — how many minutes of walking, how many flights of stairs — and how many minutes of rest settle them
Any pain at rest or at night — if yes, tell the doctor at once
Whether tiredness began after starting a particular medicine, and any black stools or pallor

Documents to bring

Procedure summary: which artery, how many stents, what date, and the angiogram result for the second artery
Full medicine list, including herbs and supplements
Previous ECGs and the latest blood results

Thailand context

Medical emergency in Thailand: call 1669
Access to repeat angiography, FFR/iFR, IVUS/OCT, drug-coated balloons and cardiac rehabilitation, and insurance coverage, vary by hospital — check with your hospital

Scientific mechanism (synthesized by the author)

Synthesized by
Asst. Prof. Dr. Norawit Raatpiboon:
When a balloon expands and a stent presses plaque against the wall, the artery lining is stripped and the wall injured. Platelets immediately adhere to the stent surface and release inflammatory mediators and growth factors that draw smooth muscle cells from the middle layer of the wall to migrate and divide, laying down connective tissue over the stent (neointimal hyperplasia). If this response is excessive, the lumen narrows again — restenosis. Drug-eluting stents release antiproliferative drugs such as the limus family (sirolimus, everolimus, zotarolimus), which block the mTOR pathway and arrest cells in the G1 phase, greatly reducing restenosis but also slowing the regrowth of lining cells over the struts. Over the long term, tissue inside the stent can accumulate lipid and inflammatory cells and become new plaque (neoatherosclerosis).
Until the stent is fully covered by lining cells, bare metal struts are a surface that triggers platelet clumping. Platelets are activated through two main pathways: the COX-1 enzyme that produces thromboxane A2, which aspirin blocks irreversibly, and ADP binding to the P2Y12 receptor, which clopidogrel and prasugrel block irreversibly (after conversion to their active forms in the liver, with clopidogrel depending mainly on CYP2C19) and ticagrelor blocks directly and reversibly. Using the two together shuts down mutually amplifying signals. If the drugs are stopped before the struts are covered, new platelets released from the bone marrow within days become fully active, clump on the exposed struts, and cause sudden stent thrombosis and heart attack — which explains why premature discontinuation is the strongest risk factor.
For borderline narrowings elsewhere, severity depends not only on percent stenosis but on lesion length, lumen area and how much heart muscle the artery supplies. FFR measures the ratio of pressure beyond the narrowing to aortic pressure at maximal flow, so it reflects the combined effect of these factors. Plaques with a large lipid core, thin cap and high inflammation can grow or rupture even when only mildly narrowed; intensive LDL lowering and risk-factor control stabilize plaque and reduce events at sites that have not been stented.

Frequently asked questions (FAQ)

Chest tightness 3 months after a stent: does it mean the stent is blocked?

Not necessarily. The 3 to 12 months after stenting is the window when in-stent restenosis can appear, usually as exertional chest pressure that returns gradually. But the same symptoms can come from a borderline second artery that has worsened, drug side effects such as breathlessness from ticagrelor or fatigue from a beta-blocker, anemia from gastrointestinal bleeding, or a weaker heart pump. A review found that angina persists or returns after PCI in about 20 to 40% of patients during short to medium-term follow-up, so see a cardiologist within days to find the cause rather than waiting for the routine appointment, and call emergency services (1669 in Thailand) for chest pain at rest.

The doctor said the second artery is 50/50. What does that mean?

It usually means a borderline narrowing of roughly half the artery width, not a 50% chance of something bad happening. A narrowing like this may or may not limit blood flow, so doctors measure flow with a pressure wire. An FFR of 0.80 or lower, or an iFR of 0.89 or lower, suggests the narrowing truly causes ischemia and stenting should be considered. Above those values, intensive medicines are about as safe as adding a stent. The DEFER study found that a narrowing measured as non-significant carried less than a 1% yearly risk of cardiac death or heart attack without a stent. Borderline plaques can still grow over time, so cholesterol and risk factors need strict control.

How common is in-stent restenosis and how is it treated?

With current drug-eluting stents, restenosis needing a repeat procedure occurs at about 1 to 2% per year, most often within the first 3 to 12 months, and it usually presents as exertional chest pressure that returns gradually. However, United States registry data show that about 25% present with an acute heart attack. Treatment is repeat angiography using intravascular ultrasound or optical imaging (IVUS or OCT) to check whether the stent is underexpanded or filled with tissue, followed by a drug-coated balloon or a repeat drug-eluting stent. Some people with repeated restenosis or complex multivessel disease may be considered for bypass surgery.

How is stent thrombosis different from restenosis?

Stent thrombosis happens suddenly, usually causing severe heart-attack chest pain, and can be fatal. Restenosis comes from tissue growing gradually over months, so symptoms tend to return slowly. Stent thrombosis is rare. A study of 2,229 patients with first-generation drug-eluting stents found 1.3% at 9 months, 45% of those affected died, and the strongest risk factor was stopping antiplatelet therapy too early. Newer stents have lower rates, but sudden severe chest pain always means calling emergency services at once.

Ticagrelor makes me breathless and tired. Should I stop it?

Do not stop it yourself. Breathlessness is a common side effect of ticagrelor. In the PLATO trial it occurred in 13.8% versus 7.8% with clopidogrel, and it was usually mild and often settled. Tiredness can also come from ischemia, heart failure or anemia, though. Tell your cardiologist within days. The doctor will look for other causes first and may then switch you to another antiplatelet in the same class without leaving any gap in treatment.

How long do I need dual antiplatelet therapy?

In general, ESC and AHA/ACC guidelines recommend dual antiplatelet therapy, meaning aspirin plus a P2Y12 inhibitor such as clopidogrel, prasugrel or ticagrelor, for about 6 months after PCI for chronic coronary disease and about 12 months after an acute coronary syndrome. It may be shorter for people at high bleeding risk, at the doctor’s discretion. After that, a single antiplatelet is usually continued long term. Your own duration must be decided by your cardiologist. Never stop or skip doses yourself, and always tell doctors and dentists before any procedure.

Can herbs or Thai traditional medicine replace antiplatelet drugs?

No. No herbal remedy has been shown to reopen a narrowed artery or replace stents and antiplatelet drugs. Stopping antiplatelets early sharply raises the risk of stent thrombosis. Some herbs also increase bleeding when combined with these drugs, including ginkgo, garlic extracts, high-dose turmeric or curcumin, dong quai, danshen, ginseng and high-dose fish oil. St John’s wort changes the liver enzymes involved with clopidogrel, ticagrelor and some cholesterol drugs. If you want Thai traditional medicine as complementary care, show every product to your cardiologist or pharmacist first.

What tests are needed when symptoms return after a stent?

Doctors usually start with an ECG compared with previous tracings, a blood count to look for anemia, troponin if pain occurs at rest or lasts a long time, and an echocardiogram to check pumping. If symptoms suggest ischemia, the next step is stress imaging such as stress echocardiography, nuclear scanning or cardiac MRI, or direct coronary angiography with FFR or iFR measurement and a look inside the stent with IVUS or OCT. Coronary CT angiography has limited ability to see inside stents, especially small ones.

Which symptoms mean calling emergency services immediately?

Call emergency services (1669 in Thailand) and do not drive yourself if chest pressure occurs at rest or lasts more than 10 to 15 minutes, comes with sweating, nausea or breathlessness, or spreads to the arm, jaw or back, or if there is fainting or near-fainting or sudden severe breathlessness. If you have been prescribed sublingual nitroglycerin, use it as your doctor instructed, and if pain is not better or is worse 5 minutes after one dose, call emergency services at once. For people on antiplatelets, black tarry stools, vomiting blood or coffee-ground material, or a sudden severe headache with limb weakness are also emergencies.

E-E-A-T and academic citations

Written by Asst. Prof. Dr. Norawit Raatpiboon (ผศ.ดร.นรวิชญ์ ราษฎร์พิบูลย์) — synthesized from the ESC 2023, ESC 2024, AHA/ACC 2023, ESC/EAS 2019, ESC/EACTS 2018 and ESC DAPT 2017 guidelines and PubMed research (PMIDs verified via NCBI, September 2026). Background: Coronary Heart Disease (NHLBI)

About the author · Author Hub

Medical disclaimer

This content is general education about chest tightness and fatigue after balloon angioplasty and stenting —
not a diagnosis, a reading of your angiogram, FFR or blood results, or a personal treatment order. Research figures describe groups of patients and do not predict any individual’s risk.
Drug names on this page are generic names or classes, not brand names. Do not start, stop, skip or change the dose of antiplatelets or any other medicine yourself, and tell your doctor before using any herb or supplement.
Procedures and coverage vary by hospital; check with your hospital. For chest pressure at rest or over 10–15 minutes, no relief 5 minutes after nitroglycerin, sweating, fainting, or serious bleeding, call emergency services (1669 in Thailand) immediately.